News Highlights: Top Company News of the Day
Oracle Reports Record Annual Profit, Revenue
Oracle Corp. reported an 8% revenue increase in the latest
period, ending the year with a record $40.48 billion in
Southwest Airlines Flights Thrown Into Disarray by Technical Problems
The second day in a row of disruptions led the airline to cancel
Platinum Equity Strikes Deal to Buy McGraw Hill From Apollo
The deal for the textbook publisher and educational-technology
company is valued at about $4.5 billion, including debt.
Lordstown Motors Looks to Reset Its Course a Day After CEO's Exit
Executives at the troubled startup say there is plenty of
interest in its all-electric truck and production is on track to
start in September.
Alibaba Falls Victim in Large Data Leak
A Chinese software developer trawled the popular Taobao shopping
website for eight months, collecting more than 1.1 billion pieces
of user information including IDs and phone numbers, a Chinese
court verdict said.
DraftKings Shares Fall After Research Firm Unveils Short Position
Short seller Hindenburg Research alleges that the sports-betting
company's gambling-technology subsidiary operates in countries
where gambling is banned, an allegation that DraftKings denies.
Neiman Marcus Rides a Rebound in Luxury Shoppers
After a trip through bankruptcy in 2020, the retailer plans to
invest $500 million to refresh stores and improve its digital
JPMorgan, Other Major U.S. Banks Excluded From Landmark European Bond Program
The European Union excluded some of the world's largest banks,
including Bank of America and UniCredit, from working on a nearly
$1 trillion coronavirus relief bond program, citing recent cases in
which regulators punished them for forming cartels.
PwC to Spend $12 Billion on Hiring, Expanding Expertise in AI, Cybersecurity
PricewaterhouseCoopers plans to spend $12 billion and hire
100,000 new people in areas such as artificial intelligence and
cybersecurity by 2026, the latest move by a Big Four accounting
firm to bet big on technology.
AstraZeneca Covid-19 Antibody Treatment Suffers Setback
AstraZeneca's coronavirus antibody treatment failed in
late-stage clinical trials to achieve its primary goal of
preventing symptomatic Covid-19 in people recently exposed to the
virus, the latest disappointment in a broader search for reliable
(END) Dow Jones Newswires
June 15, 2021 17:15 ET (21:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.